Newsroom | 86988 results

LAS VEGAS--(BUSINESS WIRE)--ASEMBIA AXS25 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced today the availability of Patient Watchtower, the first and only care coordination platform for specialty and rare disease patients. SaaS-based Patient Watchtower seamlessly merges complex and fragmented patient data from various sources and creates immediate actionable insights. It uses artificial intelligence and machine learning (AIML) to ena...

LOS ANGELES--(BUSINESS WIRE)--A team led by Children's Hospital Los Angeles (CHLA) has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential “bridge” to heart transplant for critically ill babies. The groundbreaking preclinical research could lead to a lifesaving alternative for supporting critically ill babies waiting for a new heart—particularly those with single-ventricle heart disease, most of whom currently die while waiting...

SAN MATEO, Calif.--(BUSINESS WIRE)--EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader of c-Met, a potential first-in-class therapy for a range of cancers driven by mutated, amplified, or overexpressed c-Met signaling. The data, which were presented in a poster at the American Association for Cancer Research (AACR) Annual Meeting, show that c-Met degrading EpiTACs demonstrate strong...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a leading clinical-stage company developing anchored drug conjugates for the treatment of cancer, today presented preliminary data highlighting the safety and biologic activity of their lead asset, tolododekin alfa (ANK-101), an anchored interleukin-12 (IL-12) drug conjugate. The data was derived from Part 1 of the first-in-human (FIH) ANCHOR Phase 1 clinical trial. The study was designed to evaluate the safety and feasibility of tolododek...

ATLANTA--(BUSINESS WIRE)--Curant Health, a multifaceted Medication Care Management® organization dedicated to the care of complex patients nationwide, is proud to announce the launch of its PlanPlus™ business unit. PlanPlus™ is solely focused on improving the clinical health outcomes of Health Plan member populations via award-winning complex care patient services, and unmatched business intelligence capabilities. Curant Health is URAC, ACHC, NABP and HITRUST certified with 12 IRB clinical stud...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, in partnership with Spatomics, which specializes in developing spatial biology research tools, today presents a poster at AACR detailing a highly sensitive, multiplexed single-cell in situ analysis method that enables simultaneous detection of ten or more protein and glycan ta...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today unveils at AACR 2025 its cutting-edge 3D bone marrow niche (BMN) in vitro models to advance hematological cancer research. Providing both the physical environment (cell-cell interactions), and the growth factor cocktail that hematological cancer cells require to thrive and proliferate, this innovativ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Throughout release, "exome-wide" should read as "genome-wide". The updated release reads: GUARDANT HEALTH LAUNCHES GUARDANT360 TISSUE, FIRST TISSUE MOLECULAR PROFILING TEST WITH COMPREHENSIVE MULTIOMIC ANALYSIS TO PROVIDE A MORE COMPLETE VIEW OF CANCER Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data First tissue comprehensive genomic profiling test to offer genome-wi...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced today that Marie E. Lamont, head of Real World Solutions (Patient Insights, Experience and Registry Solutions), and Dr. Joanne Hackett, vice president, Health System Services (Europe, Middle East, Africa and South Asia), have been honored by the Healthcare Businesswomen...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in transforming clinical real-world data (RWD) into personalized real-world evidence (RWE) and insights, has announced a strategic collaboration with Ontada®, a McKesson business and leader in community oncology RWD, clinical education, and point-of-care technologies. This collaboration will enhance the use cases for clinicians, researchers, and healthcare leaders to design care protocols, advance precision medicine and develop new tr...